Clinical trial
SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not…
NCT00003254 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00003254 |
|---|---|
| Title | SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil |
| Official title | A Phase II Trial of 5-Fluorouracil Plus 776C85 in Patients With Advanced Resistant Colorectal Cancer |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | ethynyluracil, fluorouracil |
| Enrollment | 75 |
| Start date | Apr 1, 1998 |
| Primary completion | Nov 1, 2002 |
| Completion | Oct 1, 2003 |
| First posted | Jun 16, 2004 |
| Last update posted | Mar 8, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: